verified SJR 1,342 · Q1 • database Scopus / SJR & Web of Science indexed

United States · American Association for Can...

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Cancer Prevention Research

Cancer Prevention Research is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 115. It has an SJR impact factor of 1,342 and it has a best quartile of Q1. It has an SJR impact factor of 1,342.

Cancer Prevention Research focuses its scope in these topics and keywords: cancer, carcinogenesis, inhibits, lg, miceabstract, formation, barretts, combined, globally, preventing, ...

ISSN: 1940-6207

Publisher: American Association for Cancer Research Inc.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,342 Q1

H-index 115

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,342

H-index

115

Docs (year)

Docs 3y

297

Total refs

2380

Cites 3y

786

Citable 3y

283

Cites/Doc 2y

2.13

Ref/Doc

40.34

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa

Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to Go

Chemoprevention Activity of 25-Hydroxyvitamin D in the MMTV-PyMT Mouse Model of Breast Cancer

Changes in Breast Density and Circulating Estrogens in Postmenopausal Women Receiving Adjuvant Anastrozole

CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis

Cancer Immunoprevention: A Case Report Raising the Possibility of "Immuno-interception"

Bridging Behavioral Science with Cancer Prevention and Control: Contributions of an NCI Working Group (2009-2019)

Boxing Bladder Cancer with COX-2-specific Inhibition

Body Fatness during Childhood and Adolescence, Adult Height, and Risk of Colorectal Adenoma in Women

Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer

Black Raspberry Inhibits Oral Tumors in Mice Treated with the Tobacco Smoke Constituent Dibenzo(def,p)chrysene Via Genetic and Epigenetic Alterations

Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites

SHOW MORE ARTICLES

Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma

(3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo

Assessing Efficacy in Early-Phase Cancer Prevention Trials: The Case of Oral Premalignancy

Aerosolized Bexarotene Inhibits Lung Tumorigenesis without Increasing Plasma Triglyceride and Cholesterol Levels in Mice

Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin

A Risk Model for Lung Cancer Incidence

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

A Pilot, First-in-Human, Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers

A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions

A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers

A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum -Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP

FAQs

Cancer Prevention Research has an SJR of 1,342 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Prevention Research is 25%.

Cancer Prevention Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Prevention Research?

What is the APC / publication cost?

What is the acceptance rate?